Boston, MA, United States of America

Lori K Taylor

This inventor holds 11 USPTO granted patents and 14 published patent applications, plus 2 CIPO patents and 2 EPO patents. Top assignee: Abbvie Biotechnology Ltd. Active years: 2014-2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Lori K Taylor. Retrieved from https://idiyas.com/inventor/lori-k-taylor

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 11 

% Patents Active = 100.0

 

 

Average Co-Inventor Count = 6.2

ph-index = 8

Forward Citations = 110(Granted Patents)


Location History:

  • South San Francisco, CA (US) (2015)
  • Boston, MA (US) (2014 - 2016)
  • Wadsworth, IL (US) (2014 - 2016)

Company Filing History:


Years Active: 2014-2016

Loading Chart...
Loading Chart...
Loading Chart...
11 patents (USPTO):Explore Patents

Title: Lori K Taylor: Innovator in Biotechnology

Introduction

Lori K Taylor is a prominent inventor based in Boston, MA (US). She has made significant contributions to the field of biotechnology, particularly in the development of treatments for autoimmune diseases. With a total of 11 patents to her name, her work has had a profound impact on medical science.

Latest Patents

Among her latest patents is the invention titled "Use of TNFα inhibitor." This invention describes methods of treating erosive polyarthritis by administering a TNFα antibody or an antigen-binding portion thereof. It also outlines a method for testing the efficacy of a TNFα antibody for the treatment of erosive polyarthritis. Another notable patent is "Multiple-variable dose regimen for treating idiopathic inflammatory bowel disease." This patent details multiple-variable dose methods for treating TNFα-related disorders, including Crohn's disease and psoriasis, by administering TNFα inhibitors, including TNFα antibodies. The methods include an induction or loading phase followed by a maintenance or treatment phase, where the TNF-inhibitor is administered in a higher dosage during the induction phase.

Career Highlights

Lori K Taylor is currently associated with AbbVie Biotechnology Ltd, where she continues to innovate and contribute to the field. Her work has been instrumental in advancing therapeutic options for patients suffering from chronic inflammatory conditions.

Collaborations

Lori collaborates with several talented individuals in her field, including Rebecca S Hoffman and Elliot Keith Chartash. Their combined expertise fosters a dynamic environment for innovation and research.

Conclusion

Lori K Taylor's contributions to biotechnology and her innovative patents highlight her role as a leading inventor in the medical field. Her work continues to pave the way for new treatments that improve the quality of life for many patients.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…